Interleukin-3 and granulocyte-macrophage colony-stimulating factor enhance the generation and function of dendritic cells

Immunology

Volumn 97, Issue 1, 1999, Pages 138-149

  Storozynsky, E ^a   Woodward, J G ^b   Frelinger, J G ^a   Lord, E M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; DENDRITIC CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOPHENOTYPING; INTERLEUKIN-3; LYMPHOCYTE CULTURE TEST, MIXED; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; SPLEEN; TUMOR CELLS, CULTURED;

EID: 0032935746     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00741.x     Document Type: Article

References (66)

1. 1. Pierre P., Turley S.J., Gatti E. et al. (1997) Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388, 787.
2. 2. Cella M., Engering A., Pinet V., Pieters J. & Lanzavecchia A. (1997) Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388, 782.
3. 3. Brodsky F.M. & Guagliardi L.E. (1991) The cell biology of antigen processing and presentation. Ann Rev Immunol 9, 707.
4. 4. Monaco J.J. (1995) Pathways for the processing and presentation of antigens to T cells. J Leukocyte Biol 57, 543.
5. 5. Braciale T.J. & Braciale V.L. (1992) Viral antigen presentation and MHC assembly. Semin Immunol 4, 81.
6. 6. Bevan M.J. (1976) Cross-priming for a secondary cytotoxic response to minor II antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med 143, 1283.
7. 7. Gooding L.R. & Edwards C.B. (1980) H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes. J Immunol 124, 1258.
8. 8. Rock K.L., Rothstein L., Gamble S. & Fleischacker C. (1993) Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. J Immunol 150, 438.
9. 9. Kovacsovics-Bankowski M., Clark K., Benacerraf B. & Rock K.L. (1993) Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci USA 90, 4942.
10. 10. Kovacsovics-Bankowski M. & Rock K.L. (1995) A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267, 243.
11. 11. McAdam A.J., Pulaski B.A., Storozynsky E. et al. (1995) Analysis of the effect of cytokines (interleukins 2, 3, 4, and 6, granulocyte monocyte colony-stimulating factor, and interferon-γ) on generation of primary cytotoxic T lymphocytes against a weakly immunogenic tumor. Cell Immunol 165, 183.
12. 12. Pulaski B.A., McAdam A.J., Hutter E.K., Biggar S., Lord E.M. & Frelinger J.G. (1993) Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanism. Cancer Res 53, 2112.
13. 13. Dranoff G., Jaffee E., Lazenhy A. et al. (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90, 3539.
14. 14. Pulaski B.A., Yeh K.Y., Shastri N. et al. (1996) Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex re-presentation of exogenous antigen by tumor-infiltrating antigen-presenting cells. Proc Natl Acad Sci USA 93, 3669.
15. 15. Metcalf D. (1991) Control of granulocytes and macrophages: molecular, cellular, and clinical aspects. Science 254, 529.
16. 16. Austyn J.M. (1998) Dendritic cells. Curr Opin Hematol 5, 3.
17. 17. Banchereau J. & Steinman R.M. (1998) Dendritic cells and the control of immunity. Nature 392, 245.
18. 18. Egan R.M., Yorkey C., Black R., Loh W.K., Stevens J.L. & Woodward J.G. (1996) Peptide-specific T cell clonal expansion in vivo following immunization in the eye, an immune-privileged site. J Immunol 157, 2262.
19. 19. Yeh K.-Y., McAdam A.J., Pulaski B.A., Shastri N., Frelinger J.G. & Lord E.M. (1998) IL-3 enhances both presentation of exogenous particulate antigen in association with class I major histocompatibility antigen and generation of primary tumor-specific cytolytic T lymphocytes. J Immunol 160, 5773.
20. 20. Sanderson S. & Shastri N. (1994) LacZ inducible, antigen/ MHC-specific T cell hybrids. Int Immunol 6, 369.
21. 21. Agger R., Witmer-Pack M., Romani N. et al. (1992) Two populations of splenic dendritic cells detected with M342, a new monoclonal to an intracellular antigen of interdigitating dendritic cells and some B lymphocytes. J Leukocyte Biol 52, 34.
22. 22. Swiggard W.J., Nonacs R.M., Witmer-Pack M.D., Steinman R.M. & Inaba K. (1992) Enrichment of dendritic cells by plastic adherence and EA rosetting. In: Current Protocols in Immunology (Ed. by R. Coico), p. 3.7.1-3.7.11. Greene Pub. Assoc. & J. Wiley, Sons Inc., Philadelphia, PA.
23. 23. Jones B. & Janeway C.A. Jr (1981 ) Cooperative interaction of B lymphocytes with antigen-specific helper T lymphocytes is MHC restricted. Nature 292, 547.
24. 24. Hammerling G.J., Rusch E., Tada N., Kimura S. & Hammerling U. (1982) Localization of allodeterminants on H-2Kb antigens determined with monoclonal antibodies and H-2 mutant mice. Proc Natl Acad Sci USA 79, 4737.
25. 25. Nussenzweig M.C., Steinman R.M., Witmer M.D. & Gutchinov B. (1982) A monoclonal antibody specific for mouse dendritic cells. Proc Natl Acad Sci USA 79, 161.
26. 26. Jiang W., Swiggard W.J., Heufler C. et al. (1995) The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375, 151.
27. 27. Ledbetter J.A. & Herzenberg L.A. (1979) Xenogeneic monoclonal antibodies to mouse lymphoid differentíation antigens. Immunol Rev 47, 63.
28. 28. Springer T., Galfre G., Secher D.S. & Milstein C. (1979) Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol 9, 301.
29. 29. Bhattacharya A., Dorf M.E. & Springer T.A. (1981) A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication. J Immunol 127, 2488.
30. 30. Takei F. (1985) Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2). J Immunol 134, 1403.
31. 31. Nabavi N., Freeman G.J., Gault A., Godfrey D., Nadler L.M. & Glimcher L.H. (1992) Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 360, 266.
32. 32. Freeman G.J., Borriello F., Hodes R.J. et al. (1993) Murine B7, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and ínterleukin 2 production. J Exp Med 178, 2185.
33. 33. Austyn J.M. & Gordon S. (1981) F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 11, 805.
34. 34. Unkeless J.C. (1979) Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med 150, 580.
35. 35. Metlay J.P., Witmer-Pack M.D., Agger R., Crowley M.T., Lawless D. & Steinman R.M. (1990) The distinct leukocyte integrins of mousespleen dendritic cells as identified with new hamster monoclonal antibodies. J Exp Med 171, 1753.
36. 36. Heath A.W., Wu W.W. & Howard M.C. (1994) Monoclonal antibodies to murine CD40 define two distinct functional epitopes. Eur J Immunol 24, 1828.
37. 37. Crocker P.R. & Gordon S. (1989) Mouse macrophage hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterized by a monoclonal antibody. J Exp Med 169, 1333.
38. 38. Inaba K., Inaba M., Romani N. et al. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176, 1693.
39. 39. Lu L., Hsieh M., Oriss T.B. et al. (1995) Generation of DC from mouse spleen cell cultures in response to GM-CSF: immunophenotypic and functional analyses. Immunology 84, 127.
40. 40. Riedy M.C., Muirhead K.A., Jensen C.P. & Stewart C.C. (1991) Use of a photolabeling technique to identify nonviable cells in fixed homologous or heterologous cell populations. Cytometry 12, 133.
41. 41. Steinman R.M. (1991) The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9, 271.
42. 42. Steinman R.M. & Witmer M.D. (1978) Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc Natl Acad Sci USA 75, 5132.
43. 43. Steinman R.M. & Inaba K. (1985) Stimulation of the primary mixed leukocyte reaction. Crit Rev Immunol 5, 331.
44. 44. Crowley M., Inaba K., Witmer-Pack M. & Steinman R.M. (1989) The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus. Cell Immunol 118, 108.
45. 45. Vremec D. & Shortman K. (1997) Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J Immunol 159, 565.
46. 46. Romani N., Koide S., Crowley M. et al. (1989) Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J Exp Med 169, 1169.
47. 47. Inaba K., Swiggard W.J., Inaba M. et al. (1995) Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. I. Expression on dendritic cells and other subsets of mouse leukocytes. Cell Immunol 163, 148.
48. 48. Inaba K., Inaba M., Witmer-Pack M., Hatchcock K., Hodes R. & Steinman R.M. (1995) Expression of B7 costimulator molecules on mouse dendritic cells. Adv Exp Med Biol 378, 65.
49. 49. Schuler G., Romani N. & Steinman R.M. (1985) A comparison of murine epidermal Langerhans cells with spleen dendritic cells. J Invest Dermatol 85, 99ss.
50. 50. Shen Z., Reznikoff G., Dranoff G. & Rock K.L. (1997) Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 158, 2723.
51. 51. Inaba K., Steinman R.M., Pack M.W. et al. (1992) Identification of proliferating dendritic cell precursors in mouse blood. J Exp Med 175, 1157.
52. 52. Larsen C.P., Steinman R.M., Witmer-Pack M., Hankins D.F., Morris P.J. & Austyn J.M. (1990) Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 172, 1483.
53. 53. Hanada K., Tsunoda R. & Hamada H. (1996) GM-CSF-induced in vivo expansion of splenic dendritic cells and their strong costimulation activity. J Leukocyte Biol 60, 181.
54. 54. Rock K.L. (1996) A new foreign policy: MHC class I molecules monitor the outside world. Immunol Today 17, 131.
55. 55. Pfeifer J.D., Wick M.J., Roberts R.L., Findlay K., Normark S.J. & Harding C.V. (1993) Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361, 359.
56. + T cells in vitro. Eur J Immunol 25, 1274.
57. 57. Lord E.M., Yeh K.Y., Moran J.A., Storozynsky E. & Frelinger J.G. (1998) IL-3-mediated enhancement of particulate antigen presentation by macrophages. J Immunother 21, 205.
58. 58. Schoenberger S.P., Toes R.E.M., Van Der Voort E.I.H., Offringer R. & Melief C.J.M. (1998) T-cell help for cytotoxic T lymphocytes is mediated by CD40 CD40L interactions. Nature 393, 480.
59. + T-helper and a T-killer cell. Nature 393, 474.
60. 60. Bennett S.R., Carbone F.R., Karamalis F., Flavell R.A., Miller J.F. & Heath W.R. (1998) Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393, 478.
61. 61. Huang A.Y., Golumbek P., Ahmadzadeh M., Jaffee E., Pardoll D. & Levitsky H. (1994) Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264, 961.
62. 62. Reis E Sousa C. & Germain R.N. (1995) Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J Exp Med 182, 841.
63. 63. Sallusto F., Cella M., Danieli C. & Lanzavecchia A. (1995) Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182, 389.
64. 64. Norbury C.C., Hewlett L.J., Prescott A.R., Shastri N. & Watts C. (1995) Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity 3, 783.
65. 65. Norbury C.C., Chambers B.J., Prescott A.R., Ljunggren H.G. & Watts C. (1997) Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur J Immunol 27, 280.
66. 66. Odermatt B., Eppler M., Leist T.P., Hengartner H. & Zinkernagel R.M. (1991) Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. Proc Natl Acad Sci USA 88, 8252.